Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03073629 · ClinicalTrials.gov registry record · NA

Assessing Outcomes in ED Patients With RV Failure

A NA study, sponsored by Indiana University.

Terminated
Registry status
NA
Development phase
2
Enrollment target

NCT03073629: Clinical Trial NA study, sponsored by Indiana University.

NCT03073629 is a NA study that was terminated before completion, run by Indiana University. The registered enrollment target is 2 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03073629, a NA study, was terminated before completion, sponsored by Indiana University.

TERMINATED
Registry status
NA
Development phase
2 participants
Enrollment target

Study Summary

Millions of Americans seek emergency care for acute shortness of breath, and many undergo computerized tomographic pulmonary angiography (CTPA) testing that is negative for acute disease. Management of patients with persistent shortness of breath despite normal testing continues to pose a challenge for clinicians. Right ventricular (RV) failure is a common cause of dyspnea that brings patients to the emergency department (ED), however, it is often not considered in the differential diagnosis, remains unrecognized, or patients are not properly followed up once diagnosed. Delays in diagnosis and management of RV failure are associated with poor outcomes. The investigators propose a novel clinical pathway, which entails identifying and enrolling patients with RV failure in the ED, then referring them to a specialized cardiovascular clinic where they will receive a standardized evaluation and management plan. Our hypothesis is that management of RV failure, through this pathway, will improve patient outcomes when compared to standard care. The primary outcome will assess 1-year unscheduled healthcare visits.

Interventions

  • DIAGNOSTIC_TEST Clinical Pathway

Trial Details

FieldValue
Enrollment Target 2 participants
Start Date 2017-01-01
Est. Completion 2017-02-23
Phase NA
Indiana University

890 total trials

Why NCT03073629 stopped before completion

NCT03073629 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 2 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).

The record links to 0 conditions, and to 1 intervention - of which Clinical Pathway is the first listed.

NCT03073629 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03073629 about?

NCT03073629 is a clinical study titled "Assessing Outcomes in ED Patients With RV Failure". Millions of Americans seek emergency care for acute shortness of breath, and many undergo computerized tomographic pulmonary angiography (CTPA) testing that is negative for acute disease. Management of patients with persistent shortness of breath despite normal testing continues to pose a challenge ...

What is the current status of trial NCT03073629?

This trial is currently terminated. It is a NA study. The enrollment target is 2 participants. The study started on 2017-01-01. Estimated completion is 2017-02-23.

What interventions are being tested in trial NCT03073629?

The interventions under investigation include: Clinical Pathway (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT03073629?

This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03073629's enrollment target sits among peer trials

2 1997th of 2000 the lowest of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03073629, the US trial registry maintained by the National Library of Medicine. NCT03073629 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.